What Is Amgen Inc. (AMGN) Worth in 2026?
According to the CirclFi Deep Alpha Valuation Engine, Amgen Inc.'s intrinsic value is estimated at $365.72, suggesting the stock is overvalued at its current price of $360.45. With 9 out of 12 models flagging downside (+1.5% average return), the market may be pricing in unsustainable growth. The most optimistic model, Markov DDM, places fair value at $1,197.32 (+232.2%), while EROIC — the most conservative — estimates $130.78 (-63.7%). This +295.9% gap reflects genuine analytical uncertainty about Amgen Inc.'s intrinsic worth. Among models with highest confidence, EPV lean bearish — adding weight to the bearish side of the thesis.
What Do the Models Say About AMGN?
12 of 13 models are currently active for AMGN. Of these, 3 models suggest upside while 9 models suggest overvaluation. The Bayesian DCF estimates AMGN's intrinsic value at $284.57, implying -21.1% downside from the current price. See which stocks rank higher →
How Does AMGN Rank in Drug Manufacturers - General?
Among 3 Drug Manufacturers - General stocks, AMGN ranks #1 by Quality of Company score. CirclFi's QOC score of 8.9/10 evaluates 32 fundamental signals. A score of 8.9 places AMGN in the top tier.
As a pharmaceutical industry, Amgen Inc. operates in a sector where pipeline depth and stage distribution is a critical driver of valuation. Investors evaluating AMGN should weigh these sector-specific dynamics alongside our model-derived fair values.
Is AMGN a Value Trap?
CirclFi's Value Trap algorithm assigns AMGN a score of 12/100 (SAFE). This indicates minimal risk. Fundamentals are healthy. The score cross-references apparent undervaluation against fundamental deterioration signals. Browse lowest value-trap stocks →
Multi-Model Methodology
12 of 13 models are active for Amgen Inc.. Broad coverage provides high confidence. Each model applies a fundamentally different valuation philosophy. See the complete methodology →
According to the CirclFi 32-factor quality framework, Amgen Inc.'s fundamental quality profile registers 8.9/10. This robust score captures the company's profitability depth, growth consistency, balance sheet resilience, and shareholder return track record.
The gap between the most bullish and bearish model spans +295.9% — demonstrating why single-model analysis is dangerous. Browse all stocks with 13-model coverage →
Data Sources & Confidence
Every AMGN valuation is built from SEC EDGAR XBRL filings — 700+ standardized financial tags. Macroeconomic context from FRED calibrates discount rates, while GDELT news sentiment feeds into our Sentiment SOTP model. All pipelines run daily. Read the complete data methodology →
Across AMGN's 12 active models, average confidence is 49%. Lower confidence may reflect limited history or high volatility.
CirclFi's output is a research starting point, not a buy/sell signal. All data updates daily. Read the full methodology →
Buy with Gumroad